Therapeutic potential of curcumin in diabetic retinopathy (Review)
- Authors:
- Jian Yang
- Xiao Miao
- Feng-Juan Yang
- Jin-Feng Cao
- Xin Liu
- Jin-Ling Fu
- Guan-Fang Su
-
Affiliations: Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China - Published online on: March 4, 2021 https://doi.org/10.3892/ijmm.2021.4908
- Article Number: 75
-
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
|
International Diabetes Federation (IDF): IDF Diabetes Atlas. 8th Edition. IDF; 2017, https://www.diabetesatlas.org/upload/resources/previous/files/8/IDF_DA_8e-EN-final.pdf. | |
|
Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, Morris AD, Pearson DW, Petrie JR, Philip S, et al: Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia. 54:3003–3006. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hartwig S, Greiser KH, Medenwald D, Tiller D, Herzog B, Schipf S, Ittermann T, Völzke H, Müller G, Haerting J and Kluttig A: Association of change of anthropometric measurements with incident type 2 diabetes mellitus: A pooled analysis of the prospective population-based CARLA and SHIP cohort studies. Medicine(Baltimore). 94:e13942015. | |
|
Wannamethee SG, Papacosta O, Lawlor DA, Whincup PH, Lowe GD, Ebrahim S and Sattar N: Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? the British regional heart study and British women's heart health study. Diabetologia. 55:80–87. 2012. View Article : Google Scholar | |
|
Shigiyama F, Kumashiro N, Tsuneoka Y, Igarashi H, Yoshikawa F, Kakehi S, Funato H and Hirose T: Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice. Am J Physiol Endocrinol Metab. 315:E848–E858. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Pan KY, Xu W, Mangialasche F, Fratiglioni L and Wang HX: Work-related psychosocial stress and the risk of type 2 diabetes in later life. J Intern Med. 281:601–610. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sohn EH, van Dijk HW, Jiao C, Kok PHB, Jeong W, Demirkaya N, Garmager A, Wit F, Kucukevcilioglu M, van Velthoven ME, et al: Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci USA. 113:E2655–E2664. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sahin K, Orhan C, Tuzcu M, Sahin N, Tastan H, Özercan IH, Güler O, Kahraman N, Kucuk O and Ozpolat B: Chemopreventive and antitumor efficacy of curcumin in a spontaneously developing hen ovarian cancer model. Cancer Prev Res (Phila). 11:59–67. 2018. View Article : Google Scholar | |
|
Fu H, Wang C, Yang D, Wei Z, Xu J, Hu Z, Zhang Y, Wang W, Yan R and Cai Q: Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling. J Cell Physiol. 233:4634–4642. 2018. View Article : Google Scholar | |
|
Kronski E, Fiori ME, Barbieri O, Astigiano S, Mirisola V, Killian PH, Bruno A, Pagani A, Rovera F, Pfeffer U, et al: miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol Oncol. 8:581–595. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ide H, Lu Y, Noguchi T, Muto S, Okada H, Kawato S and Horie S: Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer. Cancer Sci. 109:1230–1238. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan J, Liu R, Ma Y, Zhang Z and Xie Z: Curcumin attenuates airway inflammation and airway remolding by inhibiting NF-κB signaling and COX-2 in cigarette smoke-induced COPD mice. Inflammation. 41:1804–1814. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ding XQ, Wu WY, Jiao RQ, Gu TT, Xu Q, Pan Y and Kong LD: Curcumin and allopurinol ameliorate fructose-induced hepatic inflammation in rats via miR-200a-mediated TXNIP/NLRP3 inflammasome inhibition. Pharmacol Res. 137:64–75. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao Y, Xia J, Wu S, Lv Z, Huang S, Huang H, Su X, Cheng J and Ke Y: Curcumin inhibits acute vascular inflammation through the activation of heme oxygenase-1. Oxid Med Cell Longev. 2018:32958072018. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma S, Kulkarni SK and Chopra K: Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol. 33:940–945. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kadiyala CSR, Zheng L, Du Y, Yohannes E, Kao HY, Miyagi M and Kern TS: Acetylation of retinal histones in diabetes increases inflammatory proteins: Effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC). J Biol Chem. 287:25869–25880. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang LL, Chen H, Huang K and Zheng L: Elevated histone acetylations in Müller cells contribute to inflammation: A novel inhibitory effect of minocycline. Glia. 60:1896–1905. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yun JM, Jialal I and Devaraj S: Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. 22:450–458. 2011. View Article : Google Scholar | |
|
Gui L, Jiang S, Xie D, Yu L, Huang Y, Zhang Z and Liu Y: Analysis of complete chloroplast genomes of Curcuma and the contribution to phylogeny and adaptive evolution. Gene. 732:1443552020. View Article : Google Scholar : PubMed/NCBI | |
|
Nishino H, Tokuda H, Satomi Y, Masuda M, Osaka Y, Yogosawa S, Wada S, Mou XY, Takayasu J, Murakoshi M, et al: Cancer prevention by antioxidants. Biofactors. 22:57–61. 2004. View Article : Google Scholar | |
|
Boyanapalli SSS, Huang Y, Su Z, Cheng D, Zhang C, Guo Y, Rao R, Androulakis IP and Kong AN: Pharmacokinetics and pharmacodynamics of curcumin in regulating anti-inflammatory and epigenetic gene expression. Biopharm Drug Dispos. 39:289–297. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL and Brenner DE: Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 6:102006. View Article : Google Scholar : PubMed/NCBI | |
|
Falconieri MC, Adamo M, Monasterolo C, Bergonzi MC, Coronnello M and Bilia AR: New dendrimer-based nanoparticles enhance curcumin solubility. Planta Med. 83:420–425. 2017. | |
|
Tiyaboonchai W, Tungpradit W and Plianbangchang P: Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm. 337:299–306. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K, Liu H, Cui D, Chen Y and Wang S: Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine. 7:3667–3677. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R and Srinivas PS: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 64:353–356. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Skoupa N, Dolezel P, Ruzickova E and Mlejnek P: Apoptosis induced by the curcumin analogue EF-24 is neither mediated by oxidative stress-related mechanisms nor affected by expression of main drug transporters ABCB1 and ABCG2 in human leukemia cells. Int J Mol Sci. 18:22892017. View Article : Google Scholar : | |
|
Ingelfinger JR and Jarcho JA: Increase in the incidence of diabetes and its implications. N Engl J Med. 376:1473–1474. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Javidi MA, Kaeidi A, Mortazavi Farsani SS, Babashah S and Sadeghizadeh M: Investigating curcumin potential for diabetes cell therapy, in vitro and in vivo study. Life Sci. 239:1169082019. View Article : Google Scholar : PubMed/NCBI | |
|
Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C and Jirawatnotai S: Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 35:2121–2127. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Saud NBS: Impact of curcumin treatment on diabetic albino rats. Saudi J Biol Sci. 27:689–694. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Qihui L, Shuntian D, Xin Z, Xiaoxia Y and Zhongpei C: Protection of curcumin against streptozocin-induced pancreatic cell destruction in T2D rats. Planta Med. 86:113–120. 2020. View Article : Google Scholar | |
|
Bulboacă AE, Boarescu PM, Bolboacă SD, Blidaru M, Feștilă D, Dogaru G and Nicula CA: Comparative effect of curcumin versus liposomal curcumin on systemic pro-inflammatory cytokines profile, MCP-1 and RANTES in experimental diabetes mellitus. Int J Nanomedicine. 14:8961–8972. 2019. View Article : Google Scholar | |
|
Li J, Wu N, Chen X, Chen H, Yang X and Liu C: Curcumin protects islet cells from glucolipotoxicity by inhibiting oxidative stress and NADPH oxidase activity both in vitro and in vivo. Islets. 11:152–164. 2019. View Article : Google Scholar | |
|
Xia ZH, Jiang X, Li K, Li LX, Chen WB, Wang YX and Liu YQ: Curcumin inhibits alloxan-induced pancreatic islet cell damage via antioxidation and antiapoptosis. J Biochem Mol Toxicol. 34:e224992020. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta A, Tripathi AK, Tripathi RL, Madhu SV and Banerjee BD: Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Indian J Biochem Biophys. 44:373–378. 2007. | |
|
Aplin AC, Gelati M, Fogel E, Carnevale E and Nicosia RF: Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis. Physiol Genomics. 27:20–28. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kowluru RA and Kanwar M: Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond). 4:82007. View Article : Google Scholar | |
|
Assis RP, Arcaro CA, Gutierres VO, Oliveira JO, Costa PI, Baviera AM and Brunetti IL: Combined effects of curcumin and lycopene or bixin in yoghurt on inhibition of LDL oxidation and increases in HDL and paraoxonase levels in streptozotocin-diabetic rats. Int J Mol Sci. 18:3322017. View Article : Google Scholar : | |
|
Gutierres VO, Pinheiro CM, Assis RP, Vendramini RC, Pepato MT and Brunetti IL: Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes. Br J Nutr. 108:440–448. 2012. View Article : Google Scholar | |
|
Jiménez-Osorio AS, González-Reyes S and Pedraza-Chaverri J: Natural Nrf2 activators in diabetes. Clin Chim Acta. 448:182–192. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zuo ZF, Zhang Q and Liu XZ: Protective effects of curcumin on retinal Müller cell in early diabetic rats. Int J Ophthalmol. 6:422–424. 2013. | |
|
Liu Z, Lin H, Ye S, Liu QY, Meng Z, Zhang CM, Xia Y, Margoliash E, Rao Z and Liu XJ: Remarkably high activities of testicular cytochrome c in destroying reactive oxygen species and in triggering apoptosis. Proc Natl Acad Sci USA. 103:8965–8970. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Maugeri A, Mazzone MG, Giuliano F, Vinciguerra M, Basile G, Barchitta M and Agodi A: Curcumin modulates DNA methyltransferase functions in a cellular model of diabetic retinopathy. Oxid Med Cell Longev. 2018:54074822018. View Article : Google Scholar : PubMed/NCBI | |
|
Shishodia S, Sethi G and Aggarwal BB: Curcumin: Getting back to the roots. Ann N Y Acad Sci. 1056:206–217. 2005. View Article : Google Scholar | |
|
Chen Y, Li C, Duan S, Yuan X, Liang J and Hou S: Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Biomed Pharmacother. 118:1091952019. View Article : Google Scholar : PubMed/NCBI | |
|
Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU and Mohan V: Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosci. 28:715–721. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yang F, Yu J, Ke F, Lan M and Li D, Tan K, Ling J, Wang Y, Wu K and Li D: Curcumin alleviates diabetic retinopathy in experimental diabetic rats. Ophthalmic Res. 60:43–54. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bulboacă AE, Porfire AS, Tefas LR, Boarescu PM, Bolboacă SD, Stănescu IC, Bulboacă AC and Dogaru G: Liposomal curcumin is better than curcumin to alleviate complications in experimental diabetic mellitus. Molecules. 24:8462019. View Article : Google Scholar | |
|
Zhou P, Xie W, Meng X, Zhai Y, Dong X, Zhang X, Sun G and Sun X: Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1-dependent activation of mitophagy. Cells. 8:2132019. View Article : Google Scholar : | |
|
Brucklacher RM, Patel KM, VanGuilder HD, Bixler GV, Barber AJ, Antonetti DA, Lin CM, LaNoue KF, Gardner TW, Bronson SK and Freeman WM: Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics. 1:262008. View Article : Google Scholar : PubMed/NCBI | |
|
Yuuki T, Kanda T, Kimura Y, Kotajima N, Tamura J, Kobayashi I and Kishi S: Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications. 15:257–259. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE and Adamis AP: Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 158:147–152. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Khalfaoui T, Lizard G and Ouertani-Meddeb A: Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes. J Mol Histol. 39:243–249. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Boss JD, Singh PK, Pandya HK, Tosi J, Kim C, Tewari A, Juzych MS, Abrams GW and Kumar A: Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 58:5594–5603. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Luo DW, Zheng Z, Wang H, Fan Y, Chen F, Sun Y, Wang WJ, Sun T and Xu X: UPP mediated diabetic retinopathy via ROS/PARP and NF-κB inflammatory factor pathways. Curr Mol Med. 15:790–799. 2015. View Article : Google Scholar | |
|
Hollanders K, Van Hove I, Sergeys J, Van Bergen T, Lefevere E, Kindt N, Castermans K, Vandewalle E, van Pelt J, Moons L and Stalmans I: AMA0428, a potent rock inhibitor, attenuates early and late experimental diabetic retinopathy. Curr Eye Res. 42:260–272. 2017. View Article : Google Scholar | |
|
Ran Z, Zhang Y, Wen X and Ma J: Curcumin inhibits high glucose induced inflammatory injury in human retinal pigment epithelial cells through the ROS PI3K/AKT/mTOR signaling pathway. Mol Med Rep. 19:1024–1031. 2019. | |
|
Costagliola C, Romano V, De Tollis M, Aceto F, dell'Omo R, Romano MR, Pedicino C and Semeraro F: TNF-alpha levels in tears: A novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm. 2013:6295292013. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta SK, Kumar B, Nag TC, Agrawal SS, Agrawal R, Agrawal P, Saxena R and Srivastava S: Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, anti-oxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther. 27:123–130. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang C, Ting AT and Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:82–86. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Charrier A, Wang L, Stephenson EJ, Ghanta SV, Ko CW, Croniger CM, Bridges D and Buchner DA: Zinc finger protein 407 overexpression upregulates PPAR target gene expression and improves glucose homeostasis in mice. Am J Physiol Endocrinol Metab. 311:E869–E880. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E and Dandona P: Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: Evidence of an antiinflammatory action? J Clin Endocrinol Metab. 86:3250–3256. 2001.PubMed/NCBI | |
|
Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K and Freed MI: Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation. 106:679–684. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Shafabakhsh R, Mobini M, Raygan F, Aghadavod E, Ostadmohammadi V, Amirani E, Mansournia MA and Asemi Z: Curcumin administration and the effects on psychological status and markers of inflammation and oxidative damage in patients with type 2 diabetes and coronary heart disease. Clin Nutr ESPEN. 40:77–82. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li HY, Yang M, Li Z and Meng Z: Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress. Int J Mol Med. 39:1307–1316. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yun JH, Park SW, Kim KJ, Bae JS, Lee EH, Paek SH, Kim SU, Ye S, Kim JH and Cho CH: Endothelial STAT3 activation increases vascular leakage through downregulating tight junction proteins: Implications for diabetic retinopathy. J Cell Physiol. 232:1123–1134. 2017. View Article : Google Scholar | |
|
Shibuya M: Vascular endothelial growth factor and its receptor system: Physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 153:13–19. 2013. View Article : Google Scholar | |
|
Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y and Adamis AP: Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA. 96:10836–10841. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Mrudula T, Suryanarayana P, Srinivas PNBS and Reddy GB: Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem Biophys Res Commun. 361:528–532. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Wang P, Ying J, Chen Z and Yu S: Curcumin attenuates retinal vascular leakage by inhibiting calcium/calmodulin-dependent protein kinase II activity in streptozotocin-induced diabetes. Cell Physiol Biochem. 39:1196–1208. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Pradhan D, Dasmohapatra T and Tripathy G: Pharmacognostic evaluation of curcumin on diabetic retinopathy in alloxan-induced diabetes through NF-KB and Brn3a related mechanism. Pharmacogn J. 10:324–332. 2018. View Article : Google Scholar | |
|
Khimmaktong W, Petpiboolthai H, Sriya P and Anupunpisit V: Effects of curcumin on restoration and improvement of microvasculature characteristic in diabetic rat's choroid of eye. J Med Assoc Thai. 97(Suppl 2): S39–S46. 2014.PubMed/NCBI | |
|
Lee TK, Park JY, Yu JS, Jang TS, Oh ST, Pang C, Ko YJ, Kang KS and Kim KH: 7α,15-Dihydroxydehydroabietic acid from Pinus koraiensis inhibits the promotion of angiogenesis through down-regulation of VEGF, p-Akt and p-ERK in HUVECs. Bioorg Med Chem Lett. 28:1084–1089. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Farajipour H, Rahimian S and Taghizadeh M: Curcumin: A new candidate for retinal disease therapy? J Cell Biochem. 2018.Epub ahead of print. PubMed/NCBI | |
|
Ran Z, Zhang Y, Wen X and Ma J: Curcumin inhibits high glucose induced inflammatory injury in human retinal pigment epithelial cells through the ROS PI3K/AKT/mTOR signaling pathway. Mol Med Rep. 19:1024–1031. 2019. | |
|
Okamoto T, Yamagishi SI, Inagaki Y, Amano S, Koga K, Abe R, Takeuchi M, Ohno S, Yoshimura A and Makita Z: Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J. 16:1928–1930. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Salvucci O, Basik M, Yao L, Bianchi R and Tosato G: Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. J Leukoc Biol. 76:217–226. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, Mames RN, Segal MS, Grant MB and Scott EW: SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest. 115:86–93. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E and Byers HR: Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 4:376–383. 1998. View Article : Google Scholar | |
|
Sameermahmood Z, Balasubramanyam M, Saravanan T and Rema M: Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs). Invest Ophthalmol Vis Sci. 49:3305–3311. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Salven P, Hattori K, Heissig B and Rafii S: Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16:1471–1473. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Mohammad G and Kowluru RA: Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 52:3832–3841. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mohammad G and Kowluru RA: Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab Invest. 90:1365–1372. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Fu Y, Wang Y, Gao X, Li H and Yuan Y: Dynamic expression of HDAC3 in db/db mouse RGCs and its relationship with apoptosis and autophagy. J Diabetes Res. 2020:60867802020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, He N, Xing Y and Lu Y: Knockdown of GCN2 inhibits high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells. Clin Exp Pharmacol Physiol. 47:591–598. 2020. View Article : Google Scholar | |
|
Mathew R and White E: Why sick cells produce tumors: The protective role of autophagy. Autophagy. 3:502–505. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H and Mizushima N: Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 441:885–889. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Pahari S, Negi S, Aqdas M, Arnett E, Schlesinger LS and Agrewala JN: Induction of autophagy through CLEC4E in combination with TLR4: An innovative strategy to restrict the survival of mycobacterium tuberculosis. Autophagy. 16:1021–1043. 2020. View Article : Google Scholar : | |
|
Fernández ÁF, Sebti S, Wei Y, Zou Z, Shi M, McMillan KL, He C, Ting T, Liu Y, Chiang WC, et al: Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature. 558:136–140. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y, Dong X, Lu S, Gao Y, Sun G and Sun X: Gypenoside XVII alleviates early diabetic retinopathy by regulating Müller cell apoptosis and autophagy in db/db mice. Eur J Pharmacol. 895:1738932021. View Article : Google Scholar | |
|
de Faria JML, Duarte DA, Montemurro C, Papadimitriou A, Consonni SR and de Faria JBL: Defective autophagy in diabetic retinopathy. Invest Ophthalmol Vis Sci. 57:4356–4366. 2016. View Article : Google Scholar | |
|
Pereira C: Crosstalk between endoplasmic reticulum stress and protein misfolding in neurodegenerative diseases. ISRN Cell Biol. 2013:2013. View Article : Google Scholar | |
|
Pittalà V, Fidilio A, Lazzara F, Platania CBM, Salerno L, Foresti R, Drago F and Bucolo C: Effects of novel nitric oxide-releasing molecules against oxidative stress on retinal pigmented epithelial cells. Oxid Med Cell Longev. 2017:14208922017. View Article : Google Scholar : PubMed/NCBI | |
|
Bucolo C, Drago F, Maisto R, Romano GL, D'Agata V, Maugeri G and Giunta S: Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway. J Cell Physiol. 234:17295–17304. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Zou P, Zhao Z, Weng Q, Chen X, Ying S, Ye Q, Wang Z, Ji J and Liang G: Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation. Oncotarget. 7:16593–16609. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ye M, Qiu H, Cao Y, Zhang M, Mi Y, Yu J and Wang C: Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum. Front Pharmacol. 8:1482017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang P, Fang J, Zhang J, Ding S and Gan D: Curcumin inhibited podocyte cell apoptosis and accelerated cell autophagy in diabetic nephropathy via regulating beclin1/UVRAG/Bcl2. Diabetes Metab Syndr Obes. 13:641–652. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yao Q, Ke ZQ, Guo S, Yang XS, Zhang FX, Liu XF, Chen X, Chen HG, Ke HY and Liu C: Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis. J Mol Cell Cardiol. 124:26–34. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gürler B, Vural H, Yilmaz N, Oguz H, Satici A and Aksoy N: The role of oxidative stress in diabetic retinopathy. Eye (Lond). 5:730–735. 2000. View Article : Google Scholar | |
|
Chew EY, Klein ML, Ferris FL III, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ and Miller D: Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) report 22. Arch Ophthalmol. 114:1079–1084. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar B, Kowluru A and Kowluru RA: Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 56:2985–2995. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kowluru RA, Mishra M, Kowluru A and Kumar B: Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models. Metabolism. 65:1570–1581. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
de Melo ISV, Dos Santos AF and Bueno NB: Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 128:137–144. 2018. View Article : Google Scholar | |
|
Seo KI, Choi MS, Jung UJ, Kim HJ, Yeo J, Jeon SM and Lee MK: Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res. 52:995–1004. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Das KK, Razzaghi-Asl N, Tikare SN, Di Santo R, Costi R, Messore A, Pescatori L, Crucitti GC, Jargar JG, Dhundasi SA and Saso L: Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats. J Enzyme Inhib Med Chem. 31:99–105. 2016. View Article : Google Scholar | |
|
Kaur G, Invally M and Chintamaneni M: Influence of piperine and quercetin on antidiabetic potential of curcumin. J Complement Integr Med. 13:247–255. 2016.PubMed/NCBI | |
|
Song Z, Wang H, Zhu L, Han M, Gao Y, Du Y and Wen Y: Curcumin improves high glucose-induced INS-1 cell insulin resistance via activation of insulin signaling. Food Funct. 6:461–469. 2015. View Article : Google Scholar | |
|
Pivari F, Mingione A, Brasacchio C and Soldati L: Curcumin and type 2 diabetes mellitus: Prevention and treatment. Nutrients. 11:18372019. View Article : Google Scholar : | |
|
Kato M, Nishikawa S, Ikehata A, Dochi K, Tani T, Takahashi T, Imaizumi A and Tsuda T: Curcumin improves glucose tolerance via stimulation of glucagon-like peptide-1 secretion. Mol Nutr Food Res. 61:2017. View Article : Google Scholar | |
|
Yang YS, Su YF, Yang HW, Lee YH, Chou JI and Ueng KC: Lipid-lowering effects of curcumin in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Phytother Res. 28:1770–1777. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Peschel D, Koerting R and Nass N: Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem. 18:113–119. 2007. View Article : Google Scholar | |
|
Dou X, Fan C, Wo L, Yan J, Qian Y and Wo X: Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta Med. 74:1374–1379. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Fan C, Qian Y, Wo X, Yan J and Gao L: Effect of curcumin on the gene expression of low density lipoprotein receptors. Chin J Integr Med. 11:201–204. 2005.In Chinese. View Article : Google Scholar : PubMed/NCBI | |
|
Soni KB and Kuttan R: Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 36:273–275. 1992.PubMed/NCBI | |
|
Um MY, Hwang KH, Choi WH, Ahn J, Jung CH and Ha TY: Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits. Nutr Res. 34:886–893. 2014. View Article : Google Scholar : PubMed/NCBI |
